1. Home
  2. RYAM vs ABEO Comparison

RYAM vs ABEO Comparison

Compare RYAM & ABEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RYAM
  • ABEO
  • Stock Information
  • Founded
  • RYAM 1926
  • ABEO 1974
  • Country
  • RYAM United States
  • ABEO United States
  • Employees
  • RYAM N/A
  • ABEO N/A
  • Industry
  • RYAM Paper
  • ABEO Biotechnology: Pharmaceutical Preparations
  • Sector
  • RYAM Basic Materials
  • ABEO Health Care
  • Exchange
  • RYAM Nasdaq
  • ABEO Nasdaq
  • Market Cap
  • RYAM 255.7M
  • ABEO 304.4M
  • IPO Year
  • RYAM N/A
  • ABEO 1980
  • Fundamental
  • Price
  • RYAM $4.31
  • ABEO $6.53
  • Analyst Decision
  • RYAM Buy
  • ABEO Strong Buy
  • Analyst Count
  • RYAM 1
  • ABEO 6
  • Target Price
  • RYAM $6.00
  • ABEO $18.00
  • AVG Volume (30 Days)
  • RYAM 504.6K
  • ABEO 1.1M
  • Earning Date
  • RYAM 08-05-2025
  • ABEO 08-11-2025
  • Dividend Yield
  • RYAM N/A
  • ABEO N/A
  • EPS Growth
  • RYAM N/A
  • ABEO N/A
  • EPS
  • RYAM N/A
  • ABEO N/A
  • Revenue
  • RYAM $1,598,619,000.00
  • ABEO N/A
  • Revenue This Year
  • RYAM N/A
  • ABEO N/A
  • Revenue Next Year
  • RYAM $3.23
  • ABEO $322.37
  • P/E Ratio
  • RYAM N/A
  • ABEO N/A
  • Revenue Growth
  • RYAM 2.20
  • ABEO N/A
  • 52 Week Low
  • RYAM $3.45
  • ABEO $3.93
  • 52 Week High
  • RYAM $10.28
  • ABEO $7.32
  • Technical
  • Relative Strength Index (RSI)
  • RYAM 56.14
  • ABEO 58.79
  • Support Level
  • RYAM $4.07
  • ABEO $6.50
  • Resistance Level
  • RYAM $4.52
  • ABEO $6.84
  • Average True Range (ATR)
  • RYAM 0.17
  • ABEO 0.28
  • MACD
  • RYAM 0.01
  • ABEO 0.07
  • Stochastic Oscillator
  • RYAM 47.06
  • ABEO 59.59

About RYAM Rayonier Advanced Materials Inc.

Rayonier Advanced Materials Inc is engaged in the production of cellulose specialties, a natural polymer used in the manufacturing of various specialty chemical products, including liquid crystal displays, filters, textiles and performance additives for pharmaceutical, food and other industrial applications. The company's products are used in a variety of applications, including cigarette filters, liquid crystal displays, paints, pharmaceuticals, and food. The company operates in the reportable segments of High Purity Cellulose, Paperboard, and High-Yield Pulp. The key revenue is derived from the High Purity Cellulose segment. Geographically, it derives a majority of its revenue from the United States.

About ABEO Abeona Therapeutics Inc.

Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.

Share on Social Networks: